Matthew advises on a wide range of EU, UK and global competition law matters including cartels and abuse of dominance investigations, competition litigation, merger control and behavioural competition law compliance issues.
Matthew has a broad experience working across a variety of sectors including pharmaceuticals, aviation, groceries and technology/big data.
Advising Flynn Pharma in connection with its appeal to the UK Competition Appeal Tribunal against the CMA’s infringement decision finding that Flynn abused a dominant position by charging excessive and unfair prices for phenytoin.
Advising Prysmian in connection with various sets of follow-on damages claims before the English High Court and Competition Appeal Tribunal arising from the European Commission’s power cables cartel decision.
Advising Accord-UK/Auden Mckenzie in connection with the CMA investigation into alleged excessive and unfair pricing of hydrocortisone tablets and related alleged anti-competitive agreements.
Advising Qantas in connection with multiple follow-on damages claims before the English High Court, arising from the European Commission’s airfreight cartel decision, and parallel proceedings in Germany and the Netherlands.
Obtaining merger control clearance from the CMA for Hain Celestial’s acquisition of Yorkshire Provender, combining it with Hain Celestial’s New Covent Garden soup business.
